The increasingly popular nicotine pouches pose a lower risk of cancer than cigarettes, U.S. health officials said.

Morgan Stanley (NYSE:MS) initiated coverage on shares of Philip Morris International Inc. (NYSE:NYSE:PM) shares, bestowing an Overweight rating and establishing a price target of $140. The move ...

Analyst Lisa Lewandowski from Bank of America Securities maintained a Buy rating on Philip Morris (PM – Research Report) and keeping the price ...

Assenagon Asset Management S.A. lessened its holdings in shares of Philip Morris International Inc. (NYSE:PM – Free Report) ...

Federal health officials are backing the health benefits of nicotine pouches, ruling that Philip Morris International’s Zyn ...

Shares of Philip Morris International edged 0.4% higher in premarket action on Thursday to $120.80 vs. the 52-week range of $87.82 to $134.15. The dividend yield for new buyers of the stock is 4. ...

Morgan Stanley analyst Eric Serotta has maintained their bullish stance on PM stock, giving a Buy rating on January 10.Stay Ahead of the ...

Philip Morris to pay $1.2 mln to settle probe into ... nicotine pouches The sale of single-use vapes will be banned in England from June next year, the British government said on Thursday, seeking ...

Philip Morris International Inc. (NYSE:PM) announced on Thursday that it completed the previously announced sale of its subsidiary Vectura Group Ltd. to Molex Asia Holdings Ltd. The deal terms ...